WO2002074812A3 - Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases - Google Patents
Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases Download PDFInfo
- Publication number
- WO2002074812A3 WO2002074812A3 PCT/CA2002/000353 CA0200353W WO02074812A3 WO 2002074812 A3 WO2002074812 A3 WO 2002074812A3 CA 0200353 W CA0200353 W CA 0200353W WO 02074812 A3 WO02074812 A3 WO 02074812A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aeec
- preventing
- antibodies
- attaching
- escherichia coli
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0208124A BRPI0208124B8 (en) | 2001-03-15 | 2002-03-14 | use of an immunologically specific igy antibody for the protein paa associated with binding and deleting (aeec) virulence of Escherichia coli |
EP02708075A EP1368379B1 (en) | 2001-03-15 | 2002-03-14 | Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
DE60218636T DE60218636T2 (en) | 2001-03-15 | 2002-03-14 | Antibodies for the prevention and treatment of AEEC infections |
US10/471,914 US7445782B2 (en) | 2001-03-15 | 2002-03-14 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
CA2479270A CA2479270C (en) | 2001-03-15 | 2002-03-14 | Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
AU2002242531A AU2002242531B8 (en) | 2001-03-15 | 2002-03-14 | Antibodies for preventing and treating attaching and effacing escherichia coli (AEEC) associated diseases |
US12/257,420 US7727531B2 (en) | 2001-03-15 | 2008-10-24 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
US12/732,419 US8623372B2 (en) | 2001-03-15 | 2010-03-26 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002339436A CA2339436A1 (en) | 2001-03-15 | 2001-03-15 | Production of antibodies against virulence factors associated with strains of escherichia coli (aeec), and their use |
CA2,339,436 | 2001-03-15 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10471914 A-371-Of-International | 2002-03-14 | ||
US12/257,420 Division US7727531B2 (en) | 2001-03-15 | 2008-10-24 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074812A2 WO2002074812A2 (en) | 2002-09-26 |
WO2002074812A3 true WO2002074812A3 (en) | 2003-08-21 |
Family
ID=4168495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2002/000353 WO2002074812A2 (en) | 2001-03-15 | 2002-03-14 | Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
Country Status (9)
Country | Link |
---|---|
US (3) | US7445782B2 (en) |
EP (1) | EP1368379B1 (en) |
AT (1) | ATE356147T1 (en) |
AU (1) | AU2002242531B8 (en) |
BR (1) | BRPI0208124B8 (en) |
CA (1) | CA2339436A1 (en) |
DE (1) | DE60218636T2 (en) |
ES (1) | ES2283531T3 (en) |
WO (1) | WO2002074812A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000509270A (en) * | 1996-04-19 | 2000-07-25 | ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン | Histidine-tagged intimin and method of using intimin as an antigen carrier to stimulate an immune response and to have targeting ability |
CA2339436A1 (en) * | 2001-03-15 | 2002-09-15 | Josee Harel | Production of antibodies against virulence factors associated with strains of escherichia coli (aeec), and their use |
US7303817B2 (en) | 2001-10-24 | 2007-12-04 | Weitao Jia | Dental filling material |
US7750063B2 (en) | 2001-10-24 | 2010-07-06 | Pentron Clinical Technologies, Llc | Dental filling material |
US7204874B2 (en) | 2001-10-24 | 2007-04-17 | Pentron Clinical Technologies, Llc | Root canal filling material |
JP2006506419A (en) * | 2002-11-14 | 2006-02-23 | ノバルティス アクチエンゲゼルシャフト | Antimicrobial activity of antibodies producing reactive oxygen species |
KR20140043303A (en) | 2010-11-23 | 2014-04-09 | 팬더릭스 인코포레이티드 | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
WO2013009843A1 (en) * | 2011-07-11 | 2013-01-17 | Camas Incorporated | Compositions against bacterial toxins |
CN102940875B (en) * | 2012-10-31 | 2015-09-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | Paa albumen and antibody prepared therefrom and application |
EP3284476B1 (en) * | 2012-12-19 | 2019-09-25 | Lumen Bio LLC | Uses of a gastrokine protein |
CN105754919B (en) * | 2016-03-22 | 2019-08-30 | 南方医科大学 | A kind of EHEC O157:H7 recombination lactobacillus acidophilus carrier bacterin and its preparation method and application |
US10772141B2 (en) | 2018-06-28 | 2020-09-08 | The Chinese University Of Hong Kong | System and method for peer-to-peer wireless communication |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0873755A1 (en) * | 1997-04-23 | 1998-10-28 | Ghen Corporation | Prevention and treatment of enterohemorrhagic E. coli infection |
US6162441A (en) * | 1999-12-15 | 2000-12-19 | Republic Of Korea (Management: Rural Development Administration) | Method for the production of anti-escherichia. coli O157 : H7 antibody |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4550019A (en) * | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
US4748018A (en) * | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
US5932250A (en) | 1982-06-03 | 1999-08-03 | Dcv, Inc. | Anti-cholesterolemic egg, vaccine and method for production, and use |
JPH0832868B2 (en) * | 1990-01-16 | 1996-03-29 | 豊田合成株式会社 | Sealing parts for hydraulic cylinders |
CA2078716A1 (en) * | 1992-09-21 | 1994-03-22 | Joyce De Azavedo | Attaching and effacing protein of enterohemorrhagic e. coli |
US5367054A (en) * | 1993-04-12 | 1994-11-22 | Stolle Research & Development Corp. | Large-scale purification of egg immunoglobulin |
US5585098A (en) | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
DE9404859U1 (en) | 1994-03-22 | 1995-07-20 | Diehl Remscheid Gmbh & Co | Connection between an elastic rubber part with a hard plastic part |
US5798260A (en) * | 1994-06-24 | 1998-08-25 | Children's Hospital And Medical Center | Escherichia coli O157:H7 epithelial adhesin |
AU5431196A (en) * | 1995-03-24 | 1996-10-16 | Ophidian Pharmaceuticals | Treatment for verotoxin-producing escherichia coli |
US5972721A (en) * | 1996-03-14 | 1999-10-26 | The United States Of America As Represented By The Secretary Of The Air Force | Immunomagnetic assay system for clinical diagnosis and other purposes |
JP2000509270A (en) * | 1996-04-19 | 2000-07-25 | ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン | Histidine-tagged intimin and method of using intimin as an antigen carrier to stimulate an immune response and to have targeting ability |
JP2000511771A (en) | 1996-04-23 | 2000-09-12 | ユニバーシティー オブ ブリティッシュ コロンビア | Pathogenic E. coli-related proteins |
US5741489A (en) * | 1996-05-24 | 1998-04-21 | Anitox Corporation | Passively administered antibody that enhances feed conversion efficiency |
NZ335170A (en) * | 1996-10-02 | 2001-08-31 | Ovimmune Inc | Oral administration of chicken yolk Ig-gamma antibodies to treat disease |
US6204004B1 (en) | 1997-03-21 | 2001-03-20 | University Of Maryland, Baltimore | Immunodiagnostic test for enterohemorrhagic Escherichia coli infection |
US7208574B1 (en) * | 1997-11-12 | 2007-04-24 | The University Of British Columbia | Host receptor for pathogenic bacteria |
JP4410412B2 (en) | 1997-11-12 | 2010-02-03 | ザ ユニバーシティー オブ ブリティッシュ コロンビア | Pathogen host membrane receptor, HP90, encoded by the pathogen TIR gene |
GB9803322D0 (en) | 1998-02-16 | 1998-04-15 | Imperial College | Methods |
DE19910159A1 (en) | 1999-02-26 | 2000-09-14 | Rosemarie Heis | Specific IgY egg yolk antibodies, their extraction and their use |
US6291435B1 (en) * | 1999-03-04 | 2001-09-18 | The Governs Of The University Of Alberta | Treatment of diarrhea caused by enteropathogenic Escherichia coli |
US7241443B1 (en) * | 1999-07-15 | 2007-07-10 | Camas Incorporated | Immunogen adherence inhibitor and method of making and using same |
US7355092B2 (en) * | 1999-12-27 | 2008-04-08 | Ronald Marquardt | Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic Escherichia coli and other pathogens |
AU2001249388A1 (en) * | 2000-03-24 | 2001-10-08 | Trouw Nutrition Usa | Combination of plasma and hyperimmunized products for increased performance |
US8173783B2 (en) * | 2000-12-08 | 2012-05-08 | Good Biotech Corporation | Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and IgY antibodies obtained thereby |
US7300659B2 (en) * | 2001-01-04 | 2007-11-27 | University Of Saskatchewan | Enterohemorrhagic Escherichia coli vaccine |
US20030185856A1 (en) * | 2001-01-05 | 2003-10-02 | Nam-Hyung Lee | Method for the production of the egg containing anti-pathogenic bacteria specific antbodies(igy) and the yogurt and ice cream containing the igy |
US6939954B2 (en) * | 2001-01-30 | 2005-09-06 | The Lauridsen Group Incorporated | Isolated bovine lgG heavy chain protein and its use as an antimicrobial |
CA2339436A1 (en) * | 2001-03-15 | 2002-09-15 | Josee Harel | Production of antibodies against virulence factors associated with strains of escherichia coli (aeec), and their use |
IL148598A (en) * | 2002-03-10 | 2008-04-13 | Ely Morag | Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it |
BRPI0414267A (en) * | 2003-09-19 | 2006-11-21 | Epitopix Llc | campylobacter polypeptides and methods of use |
WO2005112658A1 (en) * | 2004-05-14 | 2005-12-01 | Agtech Products, Inc. | Method and composition for reducing e. coli disease and enhancing performance using bacillus |
US7250261B2 (en) * | 2004-05-20 | 2007-07-31 | University Of Massachusetts | EspFu nucleic acids and proteins and uses thereof |
-
2001
- 2001-03-15 CA CA002339436A patent/CA2339436A1/en not_active Abandoned
-
2002
- 2002-03-14 DE DE60218636T patent/DE60218636T2/en not_active Expired - Lifetime
- 2002-03-14 BR BRPI0208124A patent/BRPI0208124B8/en active IP Right Grant
- 2002-03-14 WO PCT/CA2002/000353 patent/WO2002074812A2/en active IP Right Grant
- 2002-03-14 ES ES02708075T patent/ES2283531T3/en not_active Expired - Lifetime
- 2002-03-14 AT AT02708075T patent/ATE356147T1/en not_active IP Right Cessation
- 2002-03-14 AU AU2002242531A patent/AU2002242531B8/en not_active Expired
- 2002-03-14 EP EP02708075A patent/EP1368379B1/en not_active Expired - Lifetime
- 2002-03-14 US US10/471,914 patent/US7445782B2/en not_active Expired - Lifetime
-
2008
- 2008-10-24 US US12/257,420 patent/US7727531B2/en not_active Expired - Lifetime
-
2010
- 2010-03-26 US US12/732,419 patent/US8623372B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0873755A1 (en) * | 1997-04-23 | 1998-10-28 | Ghen Corporation | Prevention and treatment of enterohemorrhagic E. coli infection |
US6162441A (en) * | 1999-12-15 | 2000-12-19 | Republic Of Korea (Management: Rural Development Administration) | Method for the production of anti-escherichia. coli O157 : H7 antibody |
Non-Patent Citations (4)
Title |
---|
AN H ET AL: "Distribution of a novel locus called paa (porcine attaching and effacing associated) among enteric Escherichia coli", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2000 UNITED STATES, vol. 473, 2000, pages 179 - 184, XP009012126, ISSN: 0065-2598 * |
LI Y ET AL: "HUMAN RESPONSE TO ESCHERICHIA COLI O157:H7 INFECTION: ANTIBODIES TO SECRETED VIRULENCE FACTORS", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 68, no. 9, September 2000 (2000-09-01), pages 5090 - 5095, XP002938916, ISSN: 0019-9567 * |
MARQUARDT RONALD R ET AL: "Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets.", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 23, no. 4, April 1999 (1999-04-01), pages 283 - 288, XP002244493, ISSN: 0928-8244 * |
NATARO JAMES P ET AL: "Diarrheagenic Escherichia coli.", CLINICAL MICROBIOLOGY REVIEWS, vol. 11, no. 1, January 1998 (1998-01-01), pages 142 - 201, XP002244492, ISSN: 0893-8512 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002242531B2 (en) | 2007-09-20 |
US20040086513A1 (en) | 2004-05-06 |
EP1368379A2 (en) | 2003-12-10 |
US20100183627A1 (en) | 2010-07-22 |
BR0208124A (en) | 2004-03-09 |
BRPI0208124B1 (en) | 2018-02-06 |
US8623372B2 (en) | 2014-01-07 |
ES2283531T3 (en) | 2007-11-01 |
DE60218636T2 (en) | 2007-11-15 |
DE60218636D1 (en) | 2007-04-19 |
BRPI0208124B8 (en) | 2022-05-10 |
ATE356147T1 (en) | 2007-03-15 |
US7445782B2 (en) | 2008-11-04 |
US20090092621A1 (en) | 2009-04-09 |
AU2002242531B8 (en) | 2008-04-03 |
CA2339436A1 (en) | 2002-09-15 |
WO2002074812A2 (en) | 2002-09-26 |
US7727531B2 (en) | 2010-06-01 |
EP1368379B1 (en) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2381770A1 (en) | Human ctla-4 antibodies and their uses | |
WO2002074812A3 (en) | Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases | |
WO2003066661A3 (en) | Human dr4 antibodies and uses thereof | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
EP0909814A3 (en) | Use of protein kinases for the diagnosis and treatment of Alzheimer's disease | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
WO2004007743A3 (en) | Use of cpg nucleic acids in prion-disease | |
WO2003045317A3 (en) | Therapeutic protein and treatments | |
WO2000073452A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2002056833A3 (en) | Preparation of a therapeutic composition | |
CA2334520A1 (en) | Treatment of immune diseases | |
WO2001040465A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2003000733A3 (en) | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis | |
WO2003055440A3 (en) | Compositions and methods for the treatement of immune related diseases | |
WO2000001729A3 (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome | |
AU3283199A (en) | Novel peptide diagnostic reagent and kit for detection of rickettsiosis | |
WO2001051512A3 (en) | Human and parasite orphan receptor proteins | |
AU666482B2 (en) | Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use | |
AU5569600A (en) | Novel protein and dna thereof | |
ATE329898T1 (en) | COMBINATION PREPARATION FOR THE THERAPY OF IMMUNOLOGICAL DISEASES | |
WO2001016319A3 (en) | Compositions and methods for the treatment of immune related diseases | |
EP1595879A3 (en) | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same | |
WO2002095413A3 (en) | Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia | |
RU2002100766A (en) | The bacterial strain Salmonella enteritidis No. 22 used for the manufacture of vaccines and diagnostic preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002242531 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002708075 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10471914 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002708075 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2479270 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002708075 Country of ref document: EP |